Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

This new study examines the effects of simvastatin on emotional processing, reward learning, verbal memory, and inflammation.

Emotion management concept, stones with painted faces symbolize different emotions.

The study involves an experimental medicine trial carried out with healthy volunteers. It mirrors a previous trial undertaken with a similar group of participants. Both trials have investigated medications that are widely used to treat heart diseases, by lowering cholesterol and inflammation in the blood, atorvastatin and simvastatin. Whereas atorvastatin was linked to perceiving emotions as more negative, in contrast, simvastatin led to perceiving emotions as more positive. However, simvastatin was also seen to slightly increase subjective anxiety scores, perhaps mimicking what happens with commonly used antidepressants: an initial worsening of anxiety, later followed by an improvement in depressive and anxious symptoms.

Taken together, these findings suggest the possibility that atorvastatin might worsen depression and anxiety, while simvastatin might improve symptoms of depression, although at the expense of some increase in anxiety at the beginning of treatment.

In summary

Atorvastatin, used in the previous trial, is a highly potent statin that can reach the brain. Giving atorvastatin for seven days to healthy volunteers was associated with worse emotional perceptions, linked to later development of depressive and anxiety symptoms.

Simvastatin, used in the current trial, is a less strong statin, but it is also capable of entering the brain. Giving simvastatin for seven days to healthy volunteers was associated with a small improvement of emotional perceptions, which could in time lead to a reduction of depressive symptoms.


Dr Riccardo De Giorgi, study author and Wellcome Trust Doctoral Training Fellow, University of Oxford, said:


'Our findings are intriguing because they show that two similar medications, generally used to treat heart conditions, can not only affect the brain, but also do so in opposite ways. This provides some important insights about the effects of statins on common mental disorders, such as depression and anxiety. The ability of statins to reduce excessive inflammation could eventually lead to the development of better treatments. Further clinical studies, especially in patients currently suffering from depressive illness, are needed.'

Read the full study, An experimental medicine study of the effects of simvastatin on emotional processing, reward learning, verbal memory, and inflammation in health volunteers, published in Psychopharmacology.



Please follow the link below to read the news on the NIHR BRC website.

Similar stories

Oxford researchers part of major UK initiative to understand chronic pain

Oxford pain researchers are playing a major role in a new multi-million pound research programme launched by a consortium of funders, including UKRI, Versus Arthritis, Eli Lilly and the Medical Research Foundation.

Anxiety Disorders Among Children, Assessment and Working with Families

Anxiety disorders are the most common mental health disorders among children, yet there is limited guidance on the process of assessing child anxiety disorders and sharing diagnostic outcomes with families.

Landmark New Clinical Trial Shows Benefits of Automated Virtual Reality (VR) Treatment for Severe Psychological Problems

The gameChange automated VR program is designed to treat agoraphobia in patients with psychosis. In the largest ever clinical trial of virtual reality for mental health, gameChange especially helped people whose anxiety had previously left them virtually housebound.

UK-Japanese Collaboration Researches Mental Health Challenges Faced by Young People and their Families

Dr Simona Skripkauskaite, Departments of Psychiatry and Experimental Psychology, University of Oxford, is the UK lead for one of the ten collaborative research projects jointly awarded by the Economic and Social Research Council (ESRC), the Arts and Humanities Research Council (AHRC) and the Japan Society for the Promotion of Science (JSPS), to address the challenges presented by the global pandemic.

Department of Psychiatry Recognition Awards

Today we announce the prize winners of the first Department of Psychiatry Recognition Awards. One award is designed to offer early career researchers (ECRs) the opportunity to showcase their work, motivations and aspirations for research into mental health. Alongside this we launch the 'Good Citizen' award, where all department members have been able to make nominations.

Hearing Aid Use Linked to Slower Decline in Thinking Skills

A new study, co-funded by Dementias Platform UK (DPUK), has found that hearing loss increased the risk of a precursor to dementia called mild cognitive impairment, but this increased risk is not present in people who wear hearing aids.